Phenytoin Sodium
NDC Package 62756-402-01
Package Information
Phenytoin Sodium is extended phenytoin sodium capsules are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery. Marketed by Sun Pharmaceutical Industries, Inc., this product is identified by NDC 62756-402 and is authorized under FDA application ANDA040621.
Identification & Billing
- RxCUI: 855671 - phenytoin sodium 100 MG Extended Release Oral Capsule
- RxCUI: 855671 - DPH sodium 100 MG Extended Release Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 62756 - Sun Pharmaceutical Industries, Inc.
- 62756-402 - Phenytoin Sodium
- 62756-402-01 - 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
- 62756-402 - Phenytoin Sodium
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (62756-402). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 62756-402-01 identifies a specific commercial package of 100 capsule, extended release in 1 bottle of Phenytoin Sodium, labeled by Sun Pharmaceutical Industries, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sun Pharmaceutical Industries, Inc. on December 12, 2006. The current certification is valid through December 31, 2019.
How is this Sun Pharmaceutical Industries, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 62756040201. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.